Looking Forward to 2022 Pt. II: Fibromyalgia and ME/CFS Clinical Trials Plus Six Potential Game-changers
Check out fibromyalgia and chronic fatigue syndrome clinical trials projected to end late last year or this year to see what 2022 may bring.
“Crushing It”: Large Pridgen Fibromyalgia Antiviral Trial Expected This Summer
I was a bit anxious as I waited for Dr. Pridgen to pick up. It had been a year and a half since we talked and I had heard nothing. Given Pridgen’s approach – using antivirals in a disease (fibromyalgia) that few connected with pathogens – his...
Antivirals for the Gut? Study Points To Potential New Gut (and Brain) Treatment
A Gulf War Illness study finds a connection between dysregulated gut flora, leaky gut and neuroinflammation – and a new way to potentially resolve it. It’s nice when the government has your back. After years of neglect, the federal government finally...Dr. Peterson Attempts to AMPlify Therapies for M.E.
Dr. Peterson’s been using Ampligen in ME/CFS for 27 years. It seems like the drug has been sitting in limbo regarding ME/CFS forever – yet Ampligen is just one phase 3 trial away from becoming the first FDA-approved drug for ME/CFS – and no other...
The NIH ME/CFS Conference II: Lipkin’s Possibilities, Prusty’s Big Idea, Oh’s Search and Ron Davis on ALWAYS Moving Forward
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
